User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 7 results.
    • Journal article
    Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia
    Robak, Tadeusz Windyga, Jerzy Trelinski, Jacek von Depka Prondzinski, Mario Giagounidis, Aristoteles Doyen, Chantal[UCL] Janssens, Ann Álvarez-Román, María Teresa Jarque, Isidro Loscertales, Javier Pérez Rus, Gloria Hellmann, Andrzej Jêdrzejczak, Wiesław Wiktor Kuliczkowski, Kazimierz Golubovic, Lana M. Celeketic, Dusica Cucuianu, Andrei Gheorghita, Emanuil Lazaroiu, Mihaela Shpilberg, Ofer Attias, Dina> Karyagina, Elena (2012) Blood — Vol. 120, no. 18, p. 3670-3676 (2012)
    • Journal article
    Efficacy and safety of frontline rituximab, cyclophosphamide, doxorubicin and prednisone plus bortezomib (VR-CAP) or vincristine (R-CHOP) in a subset of newly diagnosed mantle cell lymphoma patients medically eligible for transplantation in the randomized, phase 3 LYM-3002 study.
    Drach, Johannes Huang, Huiqiang Samoilova, Olga Belch, Andrew Farber, Charles Bosly, André[UCL] Novak, Jan Zaucha, Jan Dascalescu, Angela Bunworasate, Udomsak Masliak, Zvenyslava Vilchevskaya, Kateryna Robak, Tadeusz Pei, Lixia Rooney, Brendan van de Velde, Helgi Cavalli, Franco (2018) Leukemia and Lymphoma — Vol. 59, no. 4, p. 896-903 (2018)
    • Journal article
    A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia.
    Awan, Farrukh T Hillmen, Peter Hellmann, Andrzej Robak, Tadeusz Hughes, Steven G Trone, Denise Shannon, Megan Flinn, Ian W Byrd, John C LUCID trial investigators Bosly, André[UCL] Van Den Neste, Eric[UCL] (2014) British Journal of Haematology — Vol. 167, no.4, p. 466-477 (2014)
    • Journal article
    Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy.
    Sonneveld, Pieter Hajek, Roman Nagler, Arnon Spencer, Andrew Bladé, Joan Robak, Tadeusz Zhuang, Sen H Harousseau, Jean-Luc Orlowski, Robert Z (2008) Cancer — Vol. 112, no.7, p. 1529-37 (2008)
    • Journal article
    Characterization of haematological parameters with bortezomib-melphalan-prednisone versus melphalan-prednisone in newly diagnosed myeloma, with evaluation of long-term outcomes and risk of thromboembolic events with use of erythropoiesis-stimulating agents: Analysis of the VISTA trial
    Richardson, Paul G. Schlag, Rudolf Khuageva, Nuriet Dimopoulos, Meletios Shpilberg, Ofer Kropff, Martin Vekemans, Marie-Christiane[UCL] Petrucci, Maria Teresa Rossiev, Viktor Hou, Jian Robak, Tadeusz Mateos, Maria-Victoria Anderson, Kenneth Esseltine, Dixie-Lee Cakana, Andrew Liu, Kevin Deraedt, William van de Velde, Helgi San Miguel, Jesús F. (2011) British Journal of Haematology — Vol. 153, no. 2, p. 212-221 (2011)
    • Journal article
    The EHA Research Roadmap: Malignant Lymphoid Diseases.
    Dreyling, Martin André, Marc[UCL] Gökbuget, Nicola Tilly, Hervé Jerkeman, Mats Gribben, John Ferreri, Andrés Morel, Pierre Stilgenbauer, Stephan Fox, Christopher Maria Ribera, José Zweegman, Sonja Aurer, Igor Bödör, Csaba Burkhardt, Birgit Buske, Christian Dollores Caballero, Maria Campo, Elias Chapuy, Bjoern Davies, Andrew de Leval, Laurence Doorduijn, Jeanette Federico, Massimo Gaulard, Philippe Gay, Francesca Ghia, Paolo Grønbæk, Kirsten Goldschmidt, Hartmut Kersten, Marie-Jose Kiesewetter, Barbara Landman-Parker, Judith Le Gouill, Steven Lenz, Georg Leppä, Sirpa Lopez-Guillermo, Armando Macintyre, Elizabeth Mantega, Maria Victoria Mateos Moreau, Philippe Moreno, Carol Nadel, Bertrand Okosun, Jessica Owen, Roger Pospisilova, Sarka Pott, Christiane Robak, Tadeusz Spina, Michelle Stamatopoulos, Kostas Stary, Jan Tarte, Karin Tedeschi, Allessandra Thieblemont, Catherine Trappe, Ralf Ulrich Trümper, Lorenz H Salles, Gilles (2022) HemaSphere — Vol. 6, no. 6, p. e726 [1-18] (2022)
    • Journal article
    Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
    Burger, Jan A Tedeschi, Alessandra Barr, Paul M Robak, Tadeusz Owen, Carolyn Ghia, Paolo Bairey, Osnat Hillmen, Peter Bartlett, Nancy L Li, Jianyong Simpson, David Grosicki, Sebastian Devereux, Stephen McCarthy, Helen Coutre, Steven Quach, Hang Gaidano, Gianluca Maslyak, Zvenyslava Stevens, Don A Janssens, Ann Van Den Neste, Eric[UCL] (2015) New England Journal of Medicine — Vol. 373, no. 25, p. 2425-2437 (2015)